Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Michal, Vrablik"'
Autor:
Tomas Fait, Michal Vrablik
Publikováno v:
Sci, Vol 6, Iss 3, p 46 (2024)
Hormone replacement therapy (HRT) is a treatment for acute climacteric syndrome, with the best effectivity. It also prevents bone loss and fractures. Ischemic heart disease prevention and cognitive function improvement have been observed with HRT, on
Externí odkaz:
https://doaj.org/article/6a7156abd89040b79b1fdfd3c661e0d6
Publikováno v:
Diagnostics, Vol 14, Iss 7, p 733 (2024)
Elevated circulating triglyceride levels have been linked to an increased risk of diabetes, although the precise mechanisms remain unclear. This study aimed to investigate whether low-density lipoprotein (LDL) cholesterol, homeostatic model assessmen
Externí odkaz:
https://doaj.org/article/773ef355b7d347a0b56b3758abcc07cf
Autor:
Maciej Banach, Joanna Lewek, Kaja Pol, Daniel Rabczenko, Serban M. Balanescu, Vladimir Blaha, Richard Ceska, Piotr Jankowski, Stanisław Surma, Genovefa Kolovou, Evangelos Liberopoulos, Florin Mitu, Magda Mitu, Franjo Husam Naji, Gyorgy Paragh, Magdalena Popławska, Michal Vrablik, Daniel Pella
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundDespite better accessibility of the effective lipid-lowering therapies, only about 20% of patients at very high cardiovascular risk achieve the low-density lipoprotein cholesterol (LDL-C) goals. There is a large disparity between European c
Externí odkaz:
https://doaj.org/article/1165775fe6cd432e8cc922e6c33f441e
Autor:
Manfredi Rizzo, Alessandro Colletti, Peter E. Penson, Niki Katsiki, Dimitri P. Mikhailidis, Peter P. Toth, Ioanna Gouni-Berthold, John Mancini, David Marais, Patrick Moriarty, Massimiliano Ruscica, Amirhossein Sahebkar, Dragos Vinereanu, Arrigo Francesco Giuseppe Cicero, Maciej Banach, Julio Acosta, Mutaz Al-Khnifsawi, Fahad Alnouri, Fahma Amar, Atanas G. Atanasov, Gani Bajraktari, Sonu Bhaskar, Agata Bielecka-Dąbrowa, Bojko Bjelakovic, Eric Bruckert, Ibadete Bytyçi, Alberto Cafferata, Richard Ceska, Arrigo F.G. Cicero, Krzysztof Chlebus, Xavier Collet, Magdalena Daccord, Olivier Descamps, Dragan Djuric, Ronen Durst, Marat V. Ezhov, Zlatko Fras, Dan Gaita, Adrian V. Hernandez, Steven R. Jones, Jacek Jozwiak, Nona Kakauridze, Amani Kallel, Amit Khera, Karam Kostner, Raimondas Kubilius, Gustavs Latkovskis, G.B. John Mancini, A. David Marais, Seth S. Martin, Julio Acosta Martinez, Mohsen Mazidi, Erkin Mirrakhimov, Andre R. Miserez, Olena Mitchenko, Natalya P. Mitkovskaya, Patrick M. Moriarty, Seyed Mohammad Nabavi, Devaki Nair, Demosthenes B. Panagiotakos, György Paragh, Daniel Pella, Zaneta Petrulioniene, Matteo Pirro, Arman Postadzhiyan, Raman Puri, Ashraf Reda, Željko Reiner, Dina Radenkovic, Michał Rakowski, Jemaa Riadh, Dimitri Richter, Maria-Corina Serban, Abdullah M.A Shehab, Aleksandr B. Shek, Cesare R. Sirtori, Claudia Stefanutti, Tomasz Tomasik, Margus Viigimaa, Pedro Valdivielso, Branislav Vohnout, Stephan von Haehling, Michal Vrablik, Nathan D. Wong, Hung-I Yeh, Jiang Zhisheng, Andreas Zirlik
Publikováno v:
Pharmacological Research, Vol 189, Iss , Pp 106679- (2023)
Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting around 10–25% of the general adult population, 15% of children, and even > 50% of individuals who have type 2 diabetes mellitus. It is a major cause of liver-related morbidit
Externí odkaz:
https://doaj.org/article/899e9c48cd3d4c8196a16bde19882118
Autor:
Alberico L. Catapano MD, PhD, Michal Vrablik MD, PhD, Yuri Karpov MD, Baptiste Berthou Lic, Megan Loy BAppSc, Marie Baccara-Dinet MD
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics, Vol 27 (2022)
Objective: In primary hypercholesterolemia many people treated with statins do not reach their plasma LDL-C goals and are at increased risk of cardiovascular disease (CVD). This study aimed to evaluate efficacy and safety of a new fixed-dose combinat
Externí odkaz:
https://doaj.org/article/f986e251ef8d4cf39d6f4e9c6bb9ff7e
Publikováno v:
Pharmaceuticals, Vol 16, Iss 4, p 577 (2023)
Dyslipidemia treatment is of major importance in reducing the risk of atherosclerotic cardiovascular disease (ASCVD), which is still the most common cause of death worldwide. During the last decade, a novel lipid-lowering drug category has emerged, i
Externí odkaz:
https://doaj.org/article/4fc927d3b68b4dbb931c05e71e9b4a55
Autor:
Sabina Oreska, Hana Storkanova, Jaroslav Kudlicka, Vladimir Tuka, Ondrej Mikes, Zdislava Krupickova, Martin Satny, Eva Chytilova, Jan Kvasnicka, Maja Spiritovic, Barbora Hermankova, Petr Cesak, Marian Rybar, Karel Pavelka, Ladislav Senolt, Herman Mann, Jiri Vencovsky, Michal Vrablik, Michal Tomcik
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundIdiopathic inflammatory myopathies (IIM) are associated with systemic inflammation, limited mobility, and glucocorticoid therapy, all of which can lead to metabolism disturbances, atherogenesis, and increased cardiovascular (CV) risk. The a
Externí odkaz:
https://doaj.org/article/c03b7dda6090431296d9101b5754bdec
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Introduction: Patients with familial hypercholesterolemia (FH) are at increased risk of premature atherosclerotic cardiovascular disease (ASCVD).Aim of study: To perform a retrospective analysis of data to assess the effects of individual lipoprotein
Externí odkaz:
https://doaj.org/article/38a8420078914e459a3253348c4ad75a
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Introduction: The cause of familial hypercholesterolemia (FH) is defect in LDL receptor or familial defect of apolipoprotein B-100 (FDB) or, rarely, defect in proprotein convertase subtilisin/kexin type 9. Identification and treatment of patients wit
Externí odkaz:
https://doaj.org/article/2b6077d64dc94e908f5878dc124b38d4
Autor:
George Athanasios Karpouzas, Eirik Ikdahl, Silvia Rollefstad, Grunde Wibetoe, Anne Grete Semb, Joseph Sexton, Patrick Durez, Maria G Tektonidou, Michal Tomčík, Dionicio Angel Galarza-Delgado, Ian Graham, Miguel A González-Gay, Solbritt Rantapää-Dahlqvist, Erkin M Mirrakhimov, Petros P Sfikakis, Virginia Pascual-Ramos, Carol Hitchon, Maria Simona Stoenoiu, Elena Myasoedova, Durga Prasanna Misra, Vikas Agarwal, Dimitrios Vassilopoulos, Piet van Riel, Bindee Kuriya, George Kitas, Rong Mu, Anne M Kerola, Karen Douglas, Andrew A Borg, Pompilio Faggiano, Cindy Crowson, Argyro Lazarini, Diane Gheta, Svetlana Myasoedova, Lev Krougly, Tatiana Valentinovna Popkova, Alena Tuchyňová, Michal Vrablik, Pavel Horak, Helena Kaspar Medkova
Publikováno v:
RMD Open, Vol 7, Iss 2 (2021)
Aim The objective was to examine the prevalence of atherosclerotic cardiovascular disease (ASCVD) and its risk factors among patients with RA with diabetes mellitus (RA-DM) and patients with RA without diabetes mellitus (RAwoDM), and to evaluate lipi
Externí odkaz:
https://doaj.org/article/9fd119c49877421cb94f10bf0d78fcbf